Results of an early access treatment protocol of daratumumab monotherapy in spanish patients with relapsed or refractory multiple myeloma
Keywords:
Daratumumab
CD38-targeted
Antibody approved
Multiple myeloma
Publisher:
Wolters Kluwer Health
Note:
This is an open access article distributed
under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work
is properly cited.
Citation:
Alegre, A. (A.); Rubia, J. (Javier) de la; Sureda-Balari, A. (Anna); et al. "Results of an early access treatment protocol of daratumumab monotherapy in spanish patients with relapsed or refractory multiple myeloma". Hemasphere. 4 (3), 2020, e380
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.